Real-world efficacy and safety of low-dose pembrolizumab in patients with advanced and refractory gynecologic cancers
- Resource Type
- Article
- Source
- In
Journal of the Formosan Medical Association April 2024 123(4):487-495 - Subject
- Language
- ISSN
- 0929-6646